期刊简介
《新医学》创刊于1969年。办刊30多年来，其内容一直以内儿科为主、兼顾各科。读者对象为各级基层医疗单位的临床医师服务。《新医学》以办精品刊物为目标，脚踏实地，求实创新，与时俱进，为我国医学事业的发展作出了自己应有的贡献。长期以来，《新医学》坚持“通过形式多样的栏目，帮助读者掌握医学新信息，提高诊疗水平”的办刊宗旨，将杂志办得独具特色。在众多医学专业期刊中，以突出医学专业知识的继续教育、可读性强而著称。近年来，为了保证《新医学》稿件的质量，编辑部已大幅增加原创论文的比重，如“查房选录”、“临床研究论文”、“临床常见诊疗错误汇编”、“中西医荟萃”、“误诊分析”、“实践荟萃”、“医生手记”等栏目刊登的均是原创论文，其中省级以上基金的稿件比重也在逐年增加。多年来，《新医学》一直被评为全国综合性医药卫生类核心期刊，2004年被《中文核心期刊要目总览》评为综合性医药卫生类核心期刊。并被确定为中国学术期刊综合评价数据库统计源期刊，同时还是“万方数据──数字化期刊群”收录期刊，中文生物医学期刊文献数据库收录期刊，中国期刊全文数据库全文收录期刊，中国生物医学期刊引文数据库收录期刊。《新医学》在同行、读者中亦颇得好评，多年来屡次参评均获奖。《新医学》近年获奖情况：1997年获第二届全国优秀科技期刊二等奖；1997年、2001年分别获广东省第二届、第三届优秀科技期刊一等奖；2001年入选国家新闻出版署主办的中国期刊方阵“双百期刊”；2005年在国家新闻出版署主办的第三届国家期刊奖评比活动入选“百种重点期刊”；2007年荣获“广东省科技期刊优秀编辑部”称号。
SCI论文投稿全程模板实例
时间：2024-03-22 09:31:25
SCI论文投稿全程模板主要包括以下几个部分：投稿信（Cover Letter）、论文正文、作者信息和致谢等。下面将详细介绍这些部分，并给出实例说明。
一、投稿信（Cover Letter）
投稿信是向编辑介绍论文内容和作者情况的重要文件，也是论文投稿过程中必不可少的一部分。在投稿信中，作者需要简要介绍论文的研究背景、目的、方法、结果和结论，同时说明论文的创新性和重要性。此外，作者还需要提供自己的联系方式和作者简介等信息。
以下是一个投稿信的实例：
Dear Editor,
We are pleased to submit our manuscript entitled "XXX" for consideration for publication in your journal. In this study, we aimed to investigate the effect of XXX on XXX in a mouse model of XXX. We found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in mice. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX.
We believe that our study is of great interest to the readers of your journal and will contribute significantly to the field of XXX research. We have carefully checked the manuscript for typographical and grammatical errors, and have ensured that the data presented are accurate and reproducible.
Please find attached the manuscript files in Word and PDF formats, as well as the figures and tables in separate files. We have also included a list of potential reviewers for your consideration. However, we would like to note that we have no conflicts of interest with any of the reviewers listed.
Thank you for considering our manuscript for publication in your journal. We look forward to hearing from you soon.
Sincerely,
[Your Name]
[Your Affiliation]
[Your Email Address]
二、论文正文
论文正文是SCI论文投稿的核心部分，包括标题、摘要、关键词、引言、方法、结果、讨论和结论等部分。在撰写论文正文时，作者需要遵循学术规范和论文写作要求，确保论文内容准确、清晰、有条理。
以下是一个论文正文的实例（仅包含部分部分）：
Title: The effect of XXX on XXX in a mouse model of XXX
Abstract: In this study, we investigated the effect of XXX on XXX in a mouse model of XXX. We found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in mice. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX.
Keywords: XXX; XXX; Mouse model; Therapeutic agent
Introduction: XXX is a common disease that affects millions of people worldwide. Current treatments for XXX are limited and often associated with side effects. Therefore, there is an urgent need to develop new therapeutic agents for the treatment of XXX. In this study, we aimed to investigate the effect of XXX on XXX in a mouse model of XXX.
Methods: We used a mouse model of XXX to investigate the effect of XXX on XXX. Mice were randomly divided into two groups: a control group and a treatment group. The treatment group received XXX at a dose of XXX mg/kg/day for XXX days. All mice were sacrificed at the end of the experiment, and the levels of XXX were measured using XXX assay.
Results: We found that the levels of XXX were significantly reduced in the treatment group compared to the control group (Figure 1). In addition, the symptoms of XXX were also improved in the treatment group (Table 1).
Discussion: Our findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX. The reduction in the levels of XXX and improvement in the symptoms of XXX observed in our study are consistent with previous reports suggesting that XXX has anti-inflammatory and antioxidant properties. However, further studies are needed to confirm the efficacy and safety of XXX in humans.
Conclusion: In conclusion, we found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in a mouse model of XXX. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX and warrant further investigation in clinical trials.
（注：以上实例中的XXX需要根据实际情况进行替换。）
三、作者信息和致谢
在论文正文的最后，作者需要提供详细的作者信息和致谢。作者信息包括作者的姓名、单位、联系方式等；致谢则是对在论文撰写过程中给予帮助和支持的人或机构表示感谢。
以下是一个作者信息和致谢的实例：
Authors: [Your Name], [Co-author's Name], [Another Co-author's Name]
Affiliations: [Your Affiliation], [Co-author's Affiliation], [Another Co-author's Affiliation]
Contact Information: [Your Email Address], [Your Phone Number]
Acknowledgments: We would like to thank [Name of Funding Agency] for providing financial support for this study. We also thank [Name of Individual] for their assistance with data collection and analysis. Finally, we would like to express our gratitude to the anonymous reviewers for their valuable comments and suggestions on the manuscript.